High Profit Trading Signals - A Blog To Share A High Profit Trading Signals And Insight About Forex, Stocks, Futures, Option Trading, ICO, BLOCKCHAIN And Bitcoin.Building the Perfect Master Plan

Wednesday, January 30, 2019

STOCK PICK: Abbott Labs (ABT): PICK ABOVE $71.80





Abbott Labs (ABT): PICK ABOVE $71.80, with a $77.70 first target, an $87 second target, and a $65.25 stop loss. Confirmation Volume Area= 6.9M, Risk Rating= 4, Industry= Medical Devices.





ABT TRADING TIP: Watch this choppy formation as it sets up for another stage higher, while the market posts gains. When reviewing new trading ideas for purchase, consider buying in pieces by following strength (DCA UP). 

Abbott Labs (ABT) rose $1.99, to $71.68, on a more than 15% increase in its recent average daily volume today. ABT discovers, develops, manufactures, and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière's disease and vestibular vertigo; pain, fever, and inflammation; migraines; and anti-infective clarithromycin, as well as provides influenza vaccine and products that regulate the physiological rhythm of the colon. Its Diagnostic Products segment offers core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automates the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detects and measures infectious agents; cartridges for blood analysis; benchtop systems and rapid tests in the areas of infectious diseases; molecular point-of-care test systems for influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test systems, as well as remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. Its Nutritional Products segment provides pediatric and adult nutritional products. Its Cardiovascular and Neuromodulation Products segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases, as well as neuromodulation devices for the management of chronic pain and movement disorders. ABT also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes. In addition, ABT offers a 1.84% dividend yield.


OUR SIGNALS ENTRIES CONFIRMED:













Our Credo: What's Good for YOU!...Good For Us and vice versa!...

 Disclaimers Investing is Inherently Risky There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money tradings and invest. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.
Share:

0 comments:


Market Quotes are powered by Investing.com

SELECT YOUR LANGUAGE

TIP JAR


BTC:
1N5sDe79TDh1dNidT6C81m7Cs7M4NrGze3

ETH: 0xfb8004f635c63F767a48251Cb3e5b28EF2a9e5AE

XRP:
rNjmUoebL46zTg1t32KYecy12nL9hyRPaF

DOGE:
DHdr8YKgJ4eZwxAjmRCZ8d56QamsFpyBru

Followers

Blog Archive

Follow by Email